Background/aim: The aim of this descriptive article is to share the experience in Ege University, Turkey with favipiravir in the treatment of severe SARS-CoV-2 pneumonia.
Materials And Methods: This retrospective descriptive study included patients diagnosed with COVID-19 who presented with or developed severe pneumonia.
Results: Forty patients who completed a full course (at least 5 days) of favipiravir were included in the study. At baseline, 30 (75%) patients required treatment for respiratory distress. Thirty-three patients (82.5%) were discharged from the hospital with full recovery, 6 patients (15%) died and 1 case (2.5%) was still at the intensive care unit (ICU) when this paper was written.
Conclusion: This study provides relevant information for the treatment of COVID-19, suggesting that favipiravir was associated with significant clinical and laboratory improvements in the majority of the patients, is a safe drug with no serious side effects and would merit further investigation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283495 | PMC |
| http://dx.doi.org/10.3906/sag-2008-33 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real‑world data.
Oncol Lett
March 2025
Department of Medical Oncology, Ege University Faculty of Medicine, Bornova, Izmir 35100, Turkey.
The present study was a retrospective single-center study. A total of 81 patients diagnosed with metastatic soft tissue sarcoma were included who received pazopanib therapy. Clinical data, including age at diagnosis, histological subtype, treatments received before pazopanib, number of metastatic sites at the time of initiation of treatment, progression-free survival and overall survival time under pazopanib treatment, side effects and response evaluation in follow-up imaging after initiation of pazopanib therapy, were recorded.
View Article and Find Full Text PDFDiverse Views and Practices on the Handling of Explanted Hardware Highlights the Need for Standardized Management.
Orthop Surg
December 2024
Department of Orthopedics and Traumatology, Ege University School of Medicine, Izmir, Turkey.
Objective: Orthopedic implants may need to be removed for various reasons. There is little data on the appropriate handling of implants after their removal from patients. This study aimed to analyze how orthopedic surgeons handle removed implants and their underlying philosophies, using data collected from a survey.
View Article and Find Full Text PDFHealth Literacy of General Surgery Patients: A Cross-sectional Study.
J Perianesth Nurs
December 2024
Department of Surgical Nursing, Nursing Faculty, Ege University, Izmir, Turkey.
Purpose: Health literacy is a complex issue that affects the health outcomes of surgical patients. This study aimed to determine the health literacy of general surgery patients.
Design: A descriptive cross-sectional study.
Flow-diverting stents in the management of extracranial carotid artery aneurysms.
Diagn Interv Radiol
December 2024
Ege University Faculty of Medicine, Department of Interventional Radiology, İzmir, Türkiye.
Purpose: This study aims to investigate the indications and therapeutic efficacy of flow-diverting stents (FDSs) in the management of extracranial carotid artery aneurysms (ECAAs) and dissections.
Methods: A retrospective analysis was conducted on 18 patients treated for ECAAs with an FDS between 2010 and 2024. Patient demographics, aneurysm characteristics, procedural details, and clinical and radiologic follow-up outcomes were extracted from medical records.
Epidemiology of heart failure in Türkiye.
Turk J Med Sci
December 2024
Department of Cardiology, Faculty of Medicine, Mersin University, Mersin, Turkiye.
Background/aim: The epidemiological data on heart failure (HF) vary between regions within the same country. We aimed to investigate the epidemiological data on HF in Türkiye across all age groups regarding seven geographical regions.
Materials And Methods: We included all patients from the Turkish population who received a first diagnosis of HF between January 1, 2016 and December 31, 2022, using ICD-10 codes from the National Electronic Healthcare Database.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!